NDAQ
62
2
M
37
12
VZ
50
3
DG
6
2
CSCO
67
4
ISRG
74
-2
BA
54
5
LH
43
-2
A
43
2
DRI
53
5
WY
54
4
HST
49
-9
PGR
65
2
VRSN
53
-4
SEE
56
6
DOW
44
10
AA
48
-12
SYK
64
-4
CAH
48
-5
NKE
36
6
NDAQ
62
2
M
37
12
VZ
50
3
DG
6
2
CSCO
67
4
ISRG
74
-2
BA
54
5
LH
43
-2
A
43
2
DRI
53
5
WY
54
4
HST
49
-9
PGR
65
2
VRSN
53
-4
SEE
56
6
DOW
44
10
AA
48
-12
SYK
64
-4
CAH
48
-5
NKE
36
6
Financhill
Back

Xtant Medical Holdings Vs. Perspective Therapeutics Industry Stock Comparison

Buy
52

XTNT
Xtant Medical Holdings

Last Price:
0.40
Seasonality Move:
-3.54%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Buy
52
Xtant Medical Holdings (XTNT) is a Buy

Is Xtant Medical Holdings a Buy, Sell or Hold?

  • The current Xtant Medical Holdings [XTNT] share price is $0.40. The Score for XTNT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • XTNT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XTNT Stock Price Chart

What is Xtant Medical Holdings's stock price today?

  • The Xtant Medical Holdings share price today is $0.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTNT is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

XTNT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 21.34 Sell
Chaikin Money Flow: -219465 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.45 - 0.55) Sell
Bollinger Bands (100): (0.53 - 0.71) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

XTNT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.43 Sell
20-day SMA: 0.49 Sell
50-day SMA: 0.56 Sell
200-day SMA: 0.76 Sell
8-day EMA: 0.43 Sell
20-day EMA: 0.48 Sell
50-day EMA: 0.54 Sell
200-day EMA: 0.72 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

Xtant Medical Holdings Earnings Growth & XTNT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $0.06 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Xtant Medical Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):